[go: up one dir, main page]

AU2001255602A1 - Methods for treating bone tumors - Google Patents

Methods for treating bone tumors

Info

Publication number
AU2001255602A1
AU2001255602A1 AU2001255602A AU5560201A AU2001255602A1 AU 2001255602 A1 AU2001255602 A1 AU 2001255602A1 AU 2001255602 A AU2001255602 A AU 2001255602A AU 5560201 A AU5560201 A AU 5560201A AU 2001255602 A1 AU2001255602 A1 AU 2001255602A1
Authority
AU
Australia
Prior art keywords
methods
treating bone
bone tumors
tumors
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255602A
Inventor
Stephen Donovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Publication of AU2001255602A1 publication Critical patent/AU2001255602A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001255602A 2000-04-28 2001-04-24 Methods for treating bone tumors Abandoned AU2001255602A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09561106 2000-04-28
US09/561,106 US6565870B1 (en) 2000-04-28 2000-04-28 Methods for treating bone tumors
PCT/US2001/013100 WO2001082961A2 (en) 2000-04-28 2001-04-24 Methods for treating bone tumors

Publications (1)

Publication Number Publication Date
AU2001255602A1 true AU2001255602A1 (en) 2001-11-12

Family

ID=24240657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255602A Abandoned AU2001255602A1 (en) 2000-04-28 2001-04-24 Methods for treating bone tumors

Country Status (3)

Country Link
US (1) US6565870B1 (en)
AU (1) AU2001255602A1 (en)
WO (1) WO2001082961A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838008B2 (en) * 1999-12-07 2010-11-23 Allergan, Inc. Methods for treating diverse cancers
US6641820B1 (en) * 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US7811584B2 (en) * 2004-06-30 2010-10-12 Allergan, Inc. Multivalent clostridial toxins
US7514088B2 (en) * 2005-03-15 2009-04-07 Allergan, Inc. Multivalent Clostridial toxin derivatives and methods of their use
US8173797B2 (en) * 2004-07-21 2012-05-08 Cornell Research Foundation, Inc. Therapeutic compounds derived from spider venom and their method of use
EP1784420B1 (en) 2004-09-01 2008-12-03 Allergan, Inc. Degradable clostridial toxins
PT2168594E (en) * 2004-09-23 2015-09-15 Toxcure Inc Treating neoplasms with neurotoxin
US8343929B2 (en) * 2004-09-23 2013-01-01 Toxcure, Inc. Treating neoplasms with neurotoxin
US8052979B2 (en) 2005-03-15 2011-11-08 Allergan, Inc. Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
ES2356883B1 (en) * 2008-07-24 2012-02-22 Bcn Peptides, S.A. COMPOSITION FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION.
AU2009319732B2 (en) 2008-11-26 2013-09-05 Toxcure, Inc. Treating neoplasms with neurotoxin
US20110070212A1 (en) * 2009-08-14 2011-03-24 Allergan, Inc. Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases
ES2424294B1 (en) 2012-03-22 2014-07-21 Lipotec, S.A. Exopolysaccharide for the treatment and / or care of skin, mucous membranes, hair and / or nails
EP2649984A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2836193B1 (en) 2012-04-13 2018-01-31 Lubrizol Advanced Materials, Inc. Compounds which inhibit neuronal exocytosis (ii)
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
US9005628B2 (en) 2012-10-04 2015-04-14 Dublin City University Biotherapy for pain
CN105451710A (en) 2013-03-22 2016-03-30 利普泰股份公司 Exogenous polysaccharides for the treatment and/or care of the skin, mucous membranes and/or nails
GB201312317D0 (en) 2013-07-09 2013-08-21 Syntaxin Ltd Cationic neurotoxins
US9216210B2 (en) 2013-12-23 2015-12-22 Dublin City University Multiprotease therapeutics for chronic pain
CN116333068A (en) 2015-01-09 2023-06-27 益普生生物创新有限公司 Cationic neurotoxin
GB201517450D0 (en) 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
GB201607901D0 (en) 2016-05-05 2016-06-22 Ipsen Biopharm Ltd Chimeric neurotoxins
EP3263710A1 (en) 2016-07-01 2018-01-03 Ipsen Biopharm Limited Production of activated clostridial neurotoxins
WO2018060351A1 (en) 2016-09-29 2018-04-05 Ipsen Biopharm Limited Hybrid neurotoxins
EP3758611B1 (en) 2018-02-26 2024-07-24 Ipsen Biopharm Limited Ultrasound apparatus to guide injection of non-cytotoxic protease
GB202103372D0 (en) 2021-03-11 2021-04-28 Ipsen Biopharm Ltd Modified clostridial neurotoxins
GB202318884D0 (en) 2023-12-11 2024-01-24 Ipsen Biopharm Ltd Formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015629A1 (en) 1993-01-15 1994-07-21 Associated Synapse Biologics Method for treating myofascial pain syndrome
GB9305735D0 (en) 1993-03-19 1993-05-05 North John R Novel agent for controlling cell activity
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
DE69434610T2 (en) 1993-12-28 2008-11-27 Allergan, Inc., Irvine Use of the neurotoxic component of botulinum toxin for the treatment of muscle spasms
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
PT1086702E (en) 1994-05-09 2005-08-31 William J Binder PRE-SYNAPTIC NEUROTOXINS FOR THE TREATMENT OF CABBAGE PAIN DUE TO ENXAQUECA
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US5837265A (en) * 1996-03-08 1998-11-17 The Regents Of The University Of California Chemically-modified clostridiatoxin with improved properties
US5721215A (en) 1996-03-20 1998-02-24 Allergan Injectable therapy for control of muscle spasms and pain related to muscle spasms
US6046178A (en) * 1997-04-18 2000-04-04 Deroyal Industries, Inc. Method and compound for treating wounds with starch hydrolysate medication
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6113915A (en) * 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin

Also Published As

Publication number Publication date
WO2001082961A2 (en) 2001-11-08
US6565870B1 (en) 2003-05-20
WO2001082961A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001255602A1 (en) Methods for treating bone tumors
AU2001227966A1 (en) Methods for treating tumors
AU2001245283A1 (en) Methods for treating aneurysms
AU2001288458A1 (en) Methods for processing animal tissues
AU2002322493A1 (en) Surgical kit for treating prostate tissue
AU2001231104A1 (en) Methods for treating diabetes
AU2002215125A1 (en) Well treatment method
GB0023701D0 (en) High-frequency ion source
AU2003275126A1 (en) Hemiasterlin derivatives for treating resistant tumors
EP1210915A3 (en) Laser treatment apparatus
AU2001252605A1 (en) Laser treatment apparatus
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU2002336405A1 (en) Methods for treating deodorizer distillate
AU1233701A (en) Methods and compositions for treating atheroma, tumors and other neoplastic tissue
AU2001237939A1 (en) Methods for treating glaucoma
IL147749A0 (en) Methods for treating therapy-resistant tumors
AUPR152100A0 (en) Method for treating coral
AU2002308642A1 (en) Methods for treating cancer
AU2002227981A1 (en) Use of antioxidants in means for treating halitosis
AU2002221521A1 (en) Immunotherapeutic combinations for the treatment of tumors
AU2001253836A1 (en) Method of treating cancer
AU2001257325A1 (en) Cancer treatment
AU2002225327A1 (en) Apparatus for aesthetic treatment
HUP0004670A2 (en) Surgical device-set for spine-fixture
AU2001288518A1 (en) Methods for treating tumors using sulfonyl compounds